Using murine knockout models, GPER overexpression and localization in the plasma membrane have been shown to be essential events for breast cancer progression [80]; its absence in the plasma membrane has been reported to have an excellent long-term prognosis for ERα+ breast cancer patients treated with tamoxifen [78]. This evidence concerns the gene ESR1 and breast cancer.